Terms: = Germ cell tumor AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
964 results:
1. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
[TBL] [Abstract] [Full Text] [Related]
2. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
[TBL] [Abstract] [Full Text] [Related]
3. Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas.
Park CJ; Kim S; Han K; Ahn SS; Kim D; Park YW; Chang JH; Kim SH; Lee SK
Yonsei Med J; 2024 May; 65(5):283-292. PubMed ID: 38653567
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a multi-modality fusion deep learning model for differentiating glioblastoma from solitary brain metastases.
Shen S; Li C; Fan Y; Lu S; Yan Z; Liu H; Zhou H; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):58-67. PubMed ID: 38615167
[TBL] [Abstract] [Full Text] [Related]
5. Pathway-based stratification of gliomas uncovers four subtypes with different TME characteristics and prognosis.
Huang R; Han B; Zhang Y; Yang J; Wang K; Liu X; Wang Z
J Cell Mol Med; 2024 Apr; 28(8):e18208. PubMed ID: 38613347
[TBL] [Abstract] [Full Text] [Related]
6. Long noncoding RNA UNC5B-AS1 suppresses cell proliferation by sponging miR-24-3p in glioblastoma multiforme.
Song Y; Chen B; Jiao H; Yi L
BMC Med Genomics; 2024 Apr; 17(1):83. PubMed ID: 38594690
[TBL] [Abstract] [Full Text] [Related]
7. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of prognosis in Glioma.
Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
[TBL] [Abstract] [Full Text] [Related]
8. Deciphering cutaneous melanoma prognosis through LDL metabolism: Single-cell transcriptomics analysis via 101 machine learning algorithms.
Xie J; Wu D; Zhang P; Zhao S; Qi M
Exp Dermatol; 2024 Apr; 33(4):e15070. PubMed ID: 38570935
[TBL] [Abstract] [Full Text] [Related]
9. Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines.
Marallano VJ; Ughetta ME; Tejero R; Nanda S; Ramalingam R; Stalbow L; Sattiraju A; Huang Y; Ramakrishnan A; Shen L; Wojcinski A; Kesari S; Zou H; Tsankov AM; Friedel RH
Sci Rep; 2024 Mar; 14(1):7246. PubMed ID: 38538643
[TBL] [Abstract] [Full Text] [Related]
10. GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure.
Jeong H; Cho YR; Gim J; Cha SK; Kim M; Kang DR
PLoS One; 2024; 19(3):e0291223. PubMed ID: 38536842
[TBL] [Abstract] [Full Text] [Related]
11. Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
Jin X; Zhu J; Yu H; Shi S; Shen K; Gu J; Yin Z; Yu Z; Wu J
PLoS One; 2024; 19(3):e0298055. PubMed ID: 38530810
[TBL] [Abstract] [Full Text] [Related]
12. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract] [Full Text] [Related]
13. NPS-2143 inhibit glioma progression by suppressing autophagy through mediating AKT-mTOR pathway.
Nie JL; Li Q; Yin HT; Yang JH; Li M; Li Q; Fan XH; Zhao QQ; Wen ZP
J Cell Mol Med; 2024 Apr; 28(7):e18221. PubMed ID: 38509759
[TBL] [Abstract] [Full Text] [Related]
14. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
15. Aggrephagy-related gene signature correlates with survival and tumor-associated macrophages in glioma: Insights from single-cell and bulk RNA sequencing.
Zhang X; Tan J; Zhang X; Pandey K; Zhong Y; Wu G; He K
Math Biosci Eng; 2024 Jan; 21(2):2407-2431. PubMed ID: 38454689
[TBL] [Abstract] [Full Text] [Related]
16. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
Li X; Fan Y; Tong J; Lou M
Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852
[TBL] [Abstract] [Full Text] [Related]
17. Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
Lofiego MF; Piazzini F; Caruso FP; Marzani F; Solmonese L; Bello E; Celesti F; Costa MC; Noviello T; Mortarini R; Anichini A; Ceccarelli M; Coral S; Di Giacomo AM; Maio M; Covre A;
J Transl Med; 2024 Mar; 22(1):223. PubMed ID: 38429759
[TBL] [Abstract] [Full Text] [Related]
18. Integrated machine learning-driven disulfidptosis profiling: CYFIP1 and EMILIN1 as therapeutic nodes in neuroblastoma.
Mengzhen Z; Xinwei H; Zeheng T; Nan L; Yang Y; Huirong Y; Kaisi F; Xiaoting D; Liucheng Y; Kai W
J Cancer Res Clin Oncol; 2024 Mar; 150(3):109. PubMed ID: 38427078
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
20. Establishment of skin cutaneous melanoma prognosis model based on vascular mimicry risk score.
Wang Y; Zou L; Song M; Zong J; Wang S; Meng L; Jia Z; Zhao L; Han X; Lu M
Medicine (Baltimore); 2024 Feb; 103(7):e36679. PubMed ID: 38363903
[TBL] [Abstract] [Full Text] [Related]
[Next]
